search
Analyzing Nitrosamines
Product Information
Industry
Discover innovative nitrosamines analysis methods by Phenomenex. Our advanced techniques ensure precise detection, empowering your research with accuracy.
Nitrosamines are known to be carcinogenic and have the potential to be intermediates in organic synthesis. Due to their potent genotoxicity, nitrosamines have been a serious cause for concern. Accurate quantitate this group of compounds in pharmaceuticals during drug development and manufacturing has now become a requirement. Below, you will find the latest resources to help you improve your LC-MS quantitation of nitrosamines. If you looking to improve your nitrosamine analysis please do not hesitate to contact us.
| Technique | Brand | Description | Recommended for: |
|---|---|---|---|
| HPLC | Gemini | 3 µm C18 150 x 4.6 mm | Ph. Eur. method for N-Nitrosamines in active substances |
| HPLC | Kinetex | 2.6 µm Biphenyl 150 x 3 mm 2.6 µm Biphenyl 150 x 4.6 mm |
Sartan drugs, metformin and ranitidine |
| HPLC | Kinetex | 2.6 µm F5 50 x 2.1 mm | Rapid analysis of genotoxic nitrosamines |
| GC | Zebron | ZB-624plus 30 m x 0.25 mm x 1.40 µm | Analysis of NDMA and NDEA in sartan drugs |
| HPLC | Luna Omega | 3 µm Polar C18 150 x 3 mm | Nitrosamine impurities in acyclovir |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
